Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
DNDi Drugs for Neglected Diseases initiative
DNDi Drugs for Neglected Diseases initiative
Activities:
Research & Development
X
LinkedIn
Trending Articles
Bevel edge or radius edge flat face tablets: Which is better for greater consumer acceptance?
Consumers and patients should perceive that their tablets are easy to swallow and devoid of any undesirable taste. Tablet manufacturers can influence acceptance of by producing...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Research & Development
Bayer and DNDi to develop oral treatment for human river blindness
German healthcare giant will provide active ingredient emodepside which shows potential as a macrofilaricidal drug
Research & Development
Old drug shows new promise to treat leishmaniasis
University of Dundee scientists study fexinidazole
Research & Development
Drug companies join forces to end neglected tropical diseases
Will expand drug donation programmes and provide US$785m to support r&d efforts
Research & Development
Sanofi and DNDi sign research collaboration deal
To generate new drugs for Neglected Tropical Diseases
Regulatory
Pfizer and DNDi enter tropical disease partnership
To support the development of improved treatments for neglected African diseases
Sustainability
Consortium to develop drugs for neglected tropical diseases
<p>A consortium has been formed to develop drugs for the treatment of African sleeping sickness and Leishmaniasis, which affect millions of people worldwide. </p>
Research & Development
Merck & Co and DNDi collaborate to find treatments for world's most neglected tropical diseases
To develop improved treatments for NTDs such as visceral leishmaniasis and Chagas disease
Subscribe now